Introduction. The aminoacyl-tRNA synthetases (ARSs) are highly diversified enzyme family that catalyze the ligation of cognate amino acids to their cognate tRNAs. For most ARSs this reaction proceeds via a two-step process. In the first step of the aminoacylation reaction, the amino acid is activated by ATP to form an enzyme-bound aminoacyl ade nylate intermediate. Then, in the second step, the aminoacyl moiety is transferred to the 3'-terminal adenosine of the cognate tRNA.
Generally, but with some exceptions, all cells or organelles in which there is protein biosynthesis have a complement of 20 enzymes. These enzymes are divided into two quite distinct structural classes on the basis of primary structure and the fold of the catalytic domain [1, 2] .
The class I synthetases possess a catalytic do main that is the Rossman dinucleotide-binding fold domain which contains the signature sequences «HIGH» and «KMSKS».
The class II enzymes have a catalytic domain consisting of seven anti-parallel /З-strands and con tains the three class II-defining motifs. Tyrosyl-tRNA synthetase (TyrRS) is a homodimeric class I ami noacyl-tRNA synthetases. This enzyme is unique among all aminoacyl-tRNA synthetases in having two types of tRNA Tyr : with a long variable loop for prokaryotes and eukaryotic organelles and with a short variable loop for archaea and eukaryotes. Also, the acceptor stem of tRNA Tyr of prokaryotes, mito chondria and chloroplasts have the G1-C72 base pair found in most tRNAs while the first base pair of tRNA Tyr of eukaryotic cytoplasm and archaea is C1-G72 [3] .
Eukaryote cytoplasmic and prokaryote tyrosyl-tRNA synthetases can not cross-aminoacylate their respective tRNAs Tvr . It has been shown that in terchange of the first base pair is sufficient for the species-specific aminoacylation [4] . Knowledges of the structural basis for such kind of co-adoptation of a synthetases to tRNAs is important for under standing of the origin of the genetic code and specificity of synthetase-tRNA recognition and also can be used for drug discovery. Therefore we cloned the tyrS gene of T. thermophilus as part of structural study of TyrRSTT and its complexes with substrates. Here we report the cloning, sequencing and sequence analysis of T. thermophilus tyrosyl-tRNA synthetase.
Materials and Methods. Restriction endonucleases, T4 DNA ligase, bulk Escherichia coli tRNA, lysozyme, the digoxygenin DNA labeling and detec tion kit were from «Boehringer» (GFR), Tub DNA polymerase and [
35 S ]-dATP [S ] from «Amersham» (Great Britain), sequence version 2.0 DNA seque ncing kit and Tag cycle sequencing kit from US Biochemical Corp. pCR2.1-TOPO vector was from «Invitrogen» (USA).
TyrRS was purified from T. thermophilus HB27 cells as described [5] . Genomic DNA from T. ther mophilus cells was purified by the method of Marmur [6] . The amino acid sequences of the N-terminal peptide and three internal peptides of the purified TyrRS were determined by the Protein and the Peptide group at EMBL, Heidelberg, by microsequencing. Appropriate oligodeoxyribonucleotides were pur chased from Genosys. The polymerase chain reaction (PCR) was carried out for 30 cycles of 1 min denaturation at 94 °С, 1 min annealing at 50 °С and 1 min elongation at 72 °С in 100 /Л reaction buffer containing 50 mM Tris-HCl, pH 9.0, 1.5 mM MgCl 2 , 20 mM ammonium sulfate, 1 /Л genomic DNA from T. thermophilus HB27, 0.2 mM dNTP, 40 pmol N-terminal primer, 40 pmol internal primer and 2.5 U Tub DNA polymerase. Both strands of the tyrS gene were sequenced by the dideoxynucleotide chaintermination method [7 ] using [
35 S ]-dATP [S ] and the Sequence version 2.0 DNA sequencing kit. To over come the problems associated with the high G-C content of DNA, the ATaq cycle sequencing kit was used.
Results and Discussion. Cloning and sequencing of the T. thermophilus tyrS gene. The purified TyrRSTT provided several short peptide sequences: an N-terminal sequence of 20 amino acid residues and several internal tryptic peptides, which were determined at EMBL, Heidelberg, by the Protein and the Peptide group. Using sequence information from an N-terminal sequence (AGTGHTPEEALALLKR-GAEE) and one internal tryptic peptide (YEAGI-PISLLVELLYPFAQ) two PCR primers (5-GCSGGS-ACGGSCACACSCCSGAGGA-3' and 5-GATSGGR-ATSCCSGCCTCGTA-3') were designed taking into account the preferential codon usage of T. thermo philus, with the third base of each codon being G or C. With these two primers, a partial gene fragment (526 bp) of TyrRSTT was amplified by polymerase chain reaction. That this fragment corresponded to a putative tyrS gene was verified by cloning into pCR2.1-TOPO vector and DNA sequencing. The sequence analysis clearly indicates that this fragmant is a 5' part of the tyrS gene. Furthermore, the translated open reading frame shows significant se quence similarities with tyrosyl-tRNA synthetases from other sources.
The PCR fragment was labelled with digoxygenin and used for Southern blot hybridization to T. thermophilus genomic DNA digested with several restriction enzymes. The 1350 bp Xmal fragment was hybridized to the probe. The fragment was cloned into the appropriate sites of plasmid pUC19, and genomic sublibrary was constructed in E. coli XL1-Blue MRFB. The positive clones were screened from the genomic sublibrary by plaque hybridization with the same probe. The 1350 bp Xmal fragment was sequenced and found to contain a full length DNA of the T. thermophilus tyrS gene. The open reading frame of the tyrS gene is composed of 1296 bp, from which the sequence of 432 amino acid residues comprising one subunit of T. thermophilus TyrRS was deduced ( fig. 1 ). The calculated relative molecular mass per subunit (48717 Da) is in agreement with that estimated by SDS-polyacrylamide gel electro phoresis (50000 Da) for the purified TyrRS from T. thermophilus cells [5 ] . From amino acid composition, the isoelectric point of 6.07 and a molar extinction coefficient at 280 nm fig. 2) .
The sequence identity between T. thermophilus TyrRS and E. coli, B. stearothermophilus or B. subtilis enzymes is relatively low (24-28 %) if compare to that of the enzymes from H. pylori, H. influenzae, A. aeolicus and D. radiodurans (40-57 %). Alignment of bacterial tyrosyl-tRNA syn thetases shows important sequence identity (about 60 %) in the catalytic domain including the «HIGH» and «KMSKS» motifs (Fig. 3) . The a-helical and C-terminal domains which have crucial role in the recognition of class II type tRNA Tyr [8 ] are less well conserved among all bacterial and mitochondrial ty rosyl-tRNA synthetases (data not shown). The most phylogenetically conserved residues in the two groups of bacterial TyrRSs are located at the junction of the KMSKS loop (residues 190-244 in TyrRSTT). Two lysines (Lys-232 and Lys-234 in TyrRSTT) in the KMSKS motif and the first histidine and glycine (His-52 and Gly-54 in TyrRSTT) in the HIGH motif are strongly conserved in both groups of eubacterial TyrRSs and are important for the binding of ATP [8 ] . On the other hand, the serine is generally conserved at the third position of KMSKS motif in the TyrRS in members of the same phylogenetic branch as T. thermophilus, whereas glycine is found at this position in the second group of the bacterial TyrRSs. Also, Lys-41 (10 residues before the HIGH motif) is important for the tyrosine binding in TyrRSTT (our unpublished data) and is absolutely phylogenetically conserved. This residue is conserved as a tyrosine in the second group of bacterial TyrRSs ( fig. 3 ) and also in the most archael and eukaryotic sequences in cluding Homo sapiens (data not shown). Among organisms of this group prokaryotic TyrRS there are human pathogenic bacteria as H. influenzae, H. pylori, Mycoplasma genitalium and Vibrio cholerae. Knowledge of such differences in the catalytically important residues could be exploited for synthesis the compounds that inhibit bacterial TyrRS spe cifically and could become potent antibacterial drugs.
Bacterial resistance to established antibiotics con tinues to pose an increasing problem in clinical practice. In this regard, aminoacyl-tRNA synthetases, and in particular tyrosyl-tRNA synthetase, provide a promising platform to develop novel antibiotics that show no cross-resistance to other classical antibiotics [9, 10] . 
